Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5401_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
15.09.2026
Размер:
14 Мб
Скачать
☆
414 Herbal Pharmacopeia
TABLE 20.1 Scope and Benets of Nanotechnology in the Development of Herbal Nanomedicines
Herbal Formulations: Key Considerations
Applications Advantages
• Carcinoma of lung, breast, stomach, liver, pancreas, colon
• Inammation/neuro- inammation
• Neuro- degenerative disorders
• Anti- cancer/Anti- oxidant
• Wound healing
• Dentistry
CHALLENGES
• Poor permeability & poor absorption
• Rapid pre- systemic & systemic metabolism
• Susceptibility to P- gp efux transport
• Risk of inconsistency in quality & quantity active principle
NANOTECHNOLOGY: PROSPECTS AND PROMISES
• ↑ Solubility
• ↑ Biocompatibility
• ↑ Stability
• ↑ Site- specicity
• ↑ Cellular uptake
HERBAL NANOMEDICINES
Applications Benets
• Nanoparticles
• Nanospheres, Nanocapsules, Nanotubes
• Nanogels & self- assembled nanogels
• Nano lipid carriers
• Solid lipid nanoparticles
• Nanovesicles: liposomes, niosomes, pro- niosomes, ethosomes,
transferosomes
• ↓ Toxicity to normal tissues
• ↓ Risk of tumor recurrence
• ↓ Risk of development of drug resistance
• ↑ Retention in blood circulation
• ↓ Toxicity to off- sites
• ↑ Bioavailability
• ↑ Duration of action
• ↑ THERAPEUTIC EFFICACY
• ↓ Frequency of administration
• ↓ Cost of therapy
• ↓ Incidences of adverse outcomes
• ↑ Bioavailability
• ↑ Duration of action
• ↑ Patient compliances
• ↑ THERAPEUTIC OUTCOMES
quality control of the nanomaterials face occupational hazards that are different from those observed in the production of conventional delivery platforms. The chapter delves into a detailed discussion of various approaches, techniques, and tools currently being employed in nanotoxicological assess­ment, highlights their benets and drawbacks and identies the existing lacunae in the regulatory guidelines, and frameworks for herbal nanomedicines specically, the need for the development of standardized protocols for assays. It provides a brief overview of the classication of nanomateri­als, based on their safety and toxicity proles. The chapter focusses on the idea that future strides in the eld of herbal nanomedicines should be oriented toward ensuring high standards of quality, and better accuracy and prediction of safety and toxicity proles of nano- formulations with exist­ing herbal constituents. By addressing these goals, the chapter seeks to provide a complete under­standing of nanomaterial safety and toxicity, promote best practices and safe- by- design approaches in the manufacture of herbal nanomedicines, in an environment- friendly and sustainable manner, and provides the right impetus for future development in enhancing therapeutic outcomes from herbal nanomedicines.
Safety Proles and Potential Toxicological Concerns of Herbal Nanomedicine 415

20.2 SAFETY ISSUES AND TOXICOLOGICAL CONCERNS WITH HERBAL NANOMEDICINES

An objective understanding of safety issues and toxicological concerns of herbal nanomedicine should be based on neutral and fair approaches. It must be made clear that any form of medicine can lead to dire consequences due to misuse, abuse, or being used irrationally in target and non- target organisms and may also adversely affect the ecosystem. This happens because any therapeutic moiety is designed to interfere with various biochemical and signaling pathways in the pathological condition in the dis­eased cell, cancer cell, or microbes, ultimately causing their death. A classic example of an adverse effect in non- target species is the feminization of sh due to estrogen in the aquatic ecosystem. Other molecules that are frequently detected in water bodies are anticancer agents, anti- inammatory drugs etc. (Mahapatra etal., 2018). Moreover, herbal- based medicines suffer from some inherent drawbacks which will be dealt with in subsequent sections. Nanosystems, or nano- formulations, themselves pose challenges due to their complexities in terms of both their fabrication and also their unique features. The withdrawal of ultra- small superparamagnetic iron oxide- based contrast agent for magnetic resonance imaging from the market after reports of adverse events should be taken into consideration during the risk assessment of nanoparticles. In several instances, herbal formulations are concomitantly adminis­tered along with conventional medicines such as antibiotics for bioburden containment. Graphene oxide NP has an afnity to adsorb these antibiotics and lower their efcacy in turn. Endogenous myeloper­oxidase can reduce the cytotoxicity of graphene oxide NPs by accelerating their degradation (Martinez etal., 2021). On the other hand, co- administered NP can alter membrane integrity and may facilitate easy access to other NPs, leading to induced toxicity as a result of the interaction effect. The toxicity of copper oxide NPs was increased by zinc oxide NPs (Forest, 2022). Moreover, spray- based herbal nano- formulations or cosmetics or cosmeceuticals may release particles into the environment during application (Martinez etal., 2021; Foulkes etal., 2020). The effect of un- degraded but exhausted NPs on the patient system as well as on the outer environment need to be investigated (Mahapatra etal.,
2018). Thus, this entire section will try to cover the various aspects associated with the safety, risk, and
toxicity of herbal nanomedicines towards mankind and biotic and abiotic components of the environ­ment from different angles, during manufacture, use, post- use storage, and disposal.
There is a lot of prejudice and misunderstanding with respect to the safety of herbal preparations. Herbal medicines may suffer from a lack of reproducibility due to variations in the content of active principles based on seasonal variation, geographical location, and biodiversity (Parusu etal., 2022). Simultaneously, inactive ingredients are often not quantied, which may adversely affect the com­position of herbal extract- based dosage forms . One of the common problems associated with the use of herb or herb- derived phytochemicals is the risk of heavy metal contamination and pesticide residues in plant or plant products during the processes of cultivation and harvesting. Other hazard­ous contaminants include toxins secreted by fungi, pyrrolizidine alkaloids, and toxic chemicals like polycyclic aromatic hydrocarbons (Łuszczki etal., 2019). Decisions on dose and dosage regimen and duration of treatment with herbal nished products should be patient- specic and based on the age and sex, genetic constitution of patients, the existence of co- morbidities, the concomitant admin­istration of drugs, dietary habits, smoking addiction, and alcohol consumption levels. Evaluation and maintenance of quality control standards for herbal formulations is a daunting task (Zhang etal., 2015; Korth, 2014). Hepatotoxicity, genotoxicity, and carcinogenicity have been reported as the most common adverse effects of herbal preparations (Qari etal., 2021; Korth, 2014). Herbal formu­lations are widely popular for the treatment of skin diseases; at the same time, however, they tend to induce photosensitization and phototoxicity (Tirumala etal., 2021). In a nutshell, herbal medicines may be said to suffer from intrinsic and extrinsic toxicity (Zhang etal., 2015). Therefore, the devel­opment of herbal preparations in a systematic manner should include investigations of their potential toxic effects on vital organs, and the elucidation of mechanisms of toxicity induction during pre­clinical stages (Guidelines by Ministry of Health, Malaysia, 2023; Jitareanu etal., 2023).
416 Herbal Pharmacopeia
The fabrication of nanostructures with herbal ingredients in compliance with principles of Good Manufacturing Practices (GMP) is a complex process in which control of the manufacturing process and its associated parameters is pivotal to ensuring reproducibility in achieving critical quality attri­butes (CQA), performance, safety, and both in vitro and in vivo stability(Foulkes etal., 2020). Slight changes in the critical material attributes (CMA) of raw materials, variation in the critical process parameters (CPP), and deviation from the prescribed limits may change the CQAs with potentially serious consequences (Soares etal., 2018). The inter- relationship among CMA, CPP, and CQA is established by statistical methods of analysis and the design of experiment tools such as response surface methodology (Pan etal., 2019). From the manufacturing aspect, as well as from the view­points of therapeutic efcacy and toxicity, it must be mentioned that NPs are unique in the sense that the excipients and the active ingredient go together into the formation of a stable and efcacious particle of nano- dimension and non- active ingredients cannot be termed as excipient in the truest sense (Hemmrich & McNeil, 2023). The concept of the “nano- paradox” needs to be understood from the viewpoint of the negative impact of manufacturing and the handling of nanomaterials by the individuals involved in the manufacturing industry. The nano- dimension, which is instrumental in the benecial biological effects, proves harmful for the industry personnel and the extent of occu­pational hazards is greatly governed by the route of exposure, and duration of exposure (Guidelines and best practices for safe handling of nanomaterials in research laboratories and industries com­piled for nano mission. DST, Govt of India, Centre for Knowledge Management of Nanoscience & Technology ( https:// dst. gov. in/).
Safety and toxicity concerns regarding nanoparticles arise more out of the shell material design and composition, fabrication technique, surface modication strategies, presence of impurities (e.g. metal ion- based catalysts as in iron, molybdenum, nickel, unreacted monomer), organic contami­nants, and resultant physicochemical properties and are inuenced less by the core material of the nanosystem (Liu etal., 2022). The shell of NP thus assumes signicance in the biocompatibility, safety, and toxicity assessment as it is the component that initially comes into contact with the living cell surface (Ahmed etal., 2019). In most of the cases, intracellular ROS levels and antioxidant defense mechanisms are affected by the above- mentioned factors, leading to a cascade of events (Shukla etal., 2005).
Engineered or manufactured nanomaterials are complex heterogeneous entities with respect to their physicochemical features and, hence, demonstrate variable pharmacokinetic (ADME – Absorption, Distribution, Metabolism and Excretion) and pharmacodynamic behaviors, efcacy, and downstream cytotoxicity. Biodegradation and clearance patterns also differ. These unique prop­erties impart versatility to nanomaterials in their application and at the same time account for the risks and hazards associated with them. Nanoscale dimensions confer upon them features entirely different from the bulk counterparts from/with which they have been fabricated. They have been reported to possess superior optical properties, electrical conductivity, chemical reactivity, catalytic activity, and adsorption efciency. Physicochemical properties that should be taken into consider­ation as inuencing nanomaterial behavior in vitro and in vivo and governing their bio- interface interaction include size, size distribution, shape, surface area, composition, crystallinity, hydrophi­licity/hydrophobicity, surface properties such as roughness, porosity, surface charge, surface chem­istry, functionalization, surface coating/grafting, element doping, and the state of aggregation/ agglomeration. Other factors which contribute to the double- edged sword of efcacy and toxicity are dose, route of administration/exposure, and duration of exposure (Abdelkader etal.;, 2023; Forest, 2022; Martinex etal., 2021; Shin etal., 2021; Akcan etal., 2020; Mahapatra etal., 2018; Soares etal., 2018; Mengying etal., 2015).
The size or hydrodynamic diameter of manufactured NP in vitro depends upon the approach adopted, whether it is top- down or bottom- up. Moreover, surfactants or stabilizers are usually added to prevent protection against aggregation which is otherwise an obvious phenomenon with natural NPs. The lower the size, the greater the risk of nanotoxicity due to an increase in the specic surface area. A tendency to aggregate/agglomerate in vitro or under physiological conditions can prove to
Safety Proles and Potential Toxicological Concerns of Herbal Nanomedicine 417
be benecial in this respect. The higher specic surface area promotes interaction and is potentially hazardous and responsible for causing damage to several vital organs such as lungs, liver, kidney, spleen, male and female reproductive organs, heart, and even brain. Nano- scale dimensions permit access across the blood–brain barrier and into the fetus by crossing the placental barrier and exhibit­ing teratogenicity. The trans- placental passage of smaller NPs may have a negative impact on fetal development (Tirumala etal., 2021). Owing to their small size, they are also removed rapidly by the macrophages (Tirumala etal., 2021; Akcan etal., 2020; Foulkes etal., 2020; Soares etal., 2018). Nano- size may also result in the photoreactivity of titanium dioxide NP (Martinez etal., 2021). It is possible to fabricate NP in various shapes as spheres, bres, rods, cages, cluster, stars, and so on. Of these, conventional spherical NPs have demonstrated the least toxicity (Abbasi etal., 2023). Gold nanostars demonstrated maximum cytotoxicity in hFOB 1.19 (fetal osteoblastic cells), 143B, and MG- 63 (osteosarcoma) cell lines (Steckiewicz etal., 2019).
The nanostructure plays a signicant role in precipitating toxicity. Carbon nanotubes are toxic for mitochondria, for example, whereas silver nanoparticles interfere with cell membrane properties and morphology (Martinez etal., 2021). Metal nanoparticles are responsible for intracellular lipid peroxidation, leading to the damage of the plasma membrane, mitochondria, and endoplasmic retic­ulum. Metal oxide nanoparticles, such as titanium dioxide, iron oxide, and cupric oxide NP, cause an imbalance in intracellular ROS- oxidized glutathione machinery in the liver. Similarly, zinc oxide NP, administered at a dose of 50mg/kg body weight to rats, proved to be toxic for the intestine and generation of superoxide dismutase (Yang & Merlin, 2023; Catalano, 2021; Akcan et al., 2020). Another problem observed with metal/metallic oxide NP is their exceptionally low rate of clearance and, hence, the high degree of accumulation in the body. In addition to this, stable metallic NPs are more biocompatible than dissolvable metallic/metal oxide NPs. The type of NP component also affected genotoxicity. Gold and superparamagnetic iron oxide NP did not affect gene regulation or protein expression in human vein endothelial cells or adipose tissue- derived stem cells, respectively, and neither did it increase ROS production in RAW264.7 macrophages (Fröhlich, 2017). Liposomes are reported to be immunotoxic, triggering complement activation- related pseudo- allergy (CARPA) (Ray etal., 2021). Tailor- made NPs with biodegradable polymers pose a different challenge. Owing to biodegradation in vivo after predetermined and predened time duration, there are changes in their surface properties and concentration, and that may lead to immunotoxicity. Moreover, the pres­ence of anti- PEG antibodies affects the performance and may lead to the elicitation of toxic effects from PEGylated NPs. NPs of different compositions have been reported to be immunosuppressive and to act as immunomodulators, and capable of generating hypersensitivity reactions. Hydrophilic NPs as mesoporous silica NPs failed to gain access across the blood–brain barrier and are less toxic, owing to the presence of silanol groups on the surface (Yang & Merlin, 2023; Liu et al., 2022). Cerebral toxicity has been observed with charged gold and manganese dioxide nanoparticles, pre­sumably due to an increase in endocytosis capacity (Tirumala etal., 2021). To secure successful intracellular drug delivery, positively charged NPs are preferred as they can escape the endosome– lysosome degradation pathway, induce less endoplasmic reticulum stress and are less deleterious for cellular membranes and organelles, (Yang & Merlin, 2023). For NPs exhibiting differences in crys­tallinity as with titanium dioxide NP, the two forms were found to have different toxicity concerns, when studied in Balb/3T3 mouse broblasts or in human bronchial epithelium cell line. The rutile lattice showed cytotoxicity as well as genotoxicity and the cellular uptake was higher with anatase form (Abbasi etal., 2023). Amorphous forms of nano- silica were more toxic to human cell lines as they generated ROS and caused DNA cleavage (Akcan etal., 2020). Nanoparticles may be coated to achieve certain specic functions, and the coating imparts charges on the NP surface which may alter biocompatibility, biodegradation, biological functions, and, ultimately, nanotoxicity pheno­types. Coated silver NPs were found to have higher biocompatibility even at higher concentrations and to produce fewer alterations in intracellular glutathione and superoxide dismutase levels in comparison to uncoated ones, although the effects were size- dependent. The coating material also affected toxicity as citrate- coated silver NP demonstrated lower toxicity than PVP- coated ones.
418 Herbal Pharmacopeia
Similarly, titanium dioxide coating offered protection against zinc ion- induced damage from zinc oxide NPs (Abbasi etal., 2023). Surface modication of gold NPs with polyethylene glycol improved overall dispersion, and distribution in the circulation, prevented opsonization, retention in liver and spleen, and facilitated hepatobiliary and renal clearance. The results were just the opposite and det­rimental when polyethyleneimine (PEI) was used for the surface modication of the same gold nanoparticles. Furthermore, PEI- modied gold nanoparticles demonstrated the formation of corona with evidence of agglomeration (Li etal., 2020; Wang etal., 2020). Doping reduces the dissolution rate of doped nanomaterials as observed with iron doped- zinc oxide NP, which led to higher in vitro and in vivo toxic manifestations such as mitochondrial damage, reactive oxygen/nitrogen species (ROS/RNS)-induced oxidative stress, interruption with development of zebrash embryo, and, nally, eliciting inammatory responses in rodent pulmonary systems (Liu etal., 2022; Yan etal.,
2019). Cellular uptake studies with nanoparticle aggregates showed contradictory results. Usually, aggregation lowered the uptake by HeLa cells; in MDA- MB 435 cells, however, the uptake was increased. With zinc oxide NP, the effect of aggregation on uptake by RAW 264.7 cells was found to be concentration- dependent. A low concentration of zinc oxide NP aggregate induced apoptosis (Abbasi etal., 2023). Due to high surface energy, nanoparticles have a natural propensity to undergo aggregation and agglomeration to achieve thermodynamic stability and in the process are them­selves modied substantially. However, due to a decrease in the specic surface area, the agglomer­ate may behave differently with reduced interaction potential and may prove to be less toxic than the native NP (Liu etal., 2022).
Thus, from the above study, it is evident that alterations in NP physicochemical attributes may have a serious impact on CQAs, cellular uptake, desired therapeutic outcomes, in vivo fate, excre­tion, and toxicity. In the light of these, the ISO/TR 13014:2012 guideline recommends estimation of the above parameters for safety and hazard assessment of nanostructures (Oberdörster, 2010).
Apart from the above- mentioned parameters, the dose of the nano- formulation, exposure time, and route of administration may affect cell viability and cytotoxicity. Monodisperse spherical meso­porous silica nanoparticles should have been ideally non- toxic, but their cytotoxic effects were found to be dose- dependent, as seen with titanium dioxide NP (Abbasi etal., 2023; Gandamalla etal., 2019). Dose- dependent toxic effects were also seen with platinum NPs on HepG2 (human hepatocellular cells) and titanium dioxide NPs in human lung epithelial cells. On the other hand, polylactic acid or magnetic mesoporous silica NPs were established as being non- toxic for both cancerous and non- cancerous cells, such as human melanocyte (NGM), broblast (FGH), and endo­thelial (HUVEC) line cells (Labrador- Rached etal. 2018; Gea etal., 2019; Helal Neto etal., 2019). An exposure time of short duration (in this case 5 minutes) of poly(N- isopropylacrylamide) (PNIPAM) and N- isopropylacrylamide/N- tert- butylacrylamide (NIPAM/BAM) polymeric NPs of varying ratios produced detectable toxicity in Vibrio scheri (Naha etal., 2009). Nano- formulations with FDA- approved constituents and administered via the oral route may adversely affect the intes­tinal mucosal barrier and may alter colonic microbiota composition (Yang etal., 2023). Due to the difference in the composition of bacterial cell membranes, Gram- positive and Gram- negative bacte­ria are affected by NPs in different manners (Martinez etal., 2021). Intravenous administration of silica and titanium dioxide NPs affected the growth and development of fetus in mice (Tirumala etal., 2021). Dermal application or intravenous administration of nano- formulations of the same composition may affect the immune system in different ways (Keck & Müller, 2013).
Protein corona formation occurs following the intravenous administration of NP, when their actual size interacting with the biological surface is more than the original size of the manufactured NP. The adsorption of different types of proteins from biological uid onto the nanomaterial surface compensates for the presence of excess energy on the particle surface (Foulkes etal., 2020; Lv etal.,
2015). Alternatively, it can be said that the pristine, synthetic identity of NP acquires a new biologi­cal identity in the body which can exhibit potentially benecial or deleterious effects. The phenom­enon of adsorption is highly dynamic owing to the variable composition of the uids coming into contact with solid nanoparticle surfaces and due to differences in the afnity of proteins. A change
Safety Proles and Potential Toxicological Concerns of Herbal Nanomedicine 419
in composition of the corona is attributed to the health condition, physiological environment, inter­nal localization of NP, co- morbidities, and the co- administration of different therapeutic moieties (Soares etal., 2018). Not only is the adsorption dynamic, but so also is the subsequent interaction with the cell membrane, and such dynamic events alter the NP surface properties in a cyclical fash­ion (Ahmad etal., 2022). The corona alters the movement of NP in the circulatory system, biodis­tribution, and metabolism, and it also accelerates NP clearance from the body as it is easily recognized by macrophages. Therapeutic outcomes have been reported to differ according to the presence or absence of protein corona on the NP surface (Forest, 2022; Bai etal., 2021; Cai etal., 2018; Ding etal., 2018).
Moreover, intentional or undesirable trafcking, bioretention, and biopersistence depend on the type of organism/cell; that is, whether it is a prokaryotic cell or an eukaryotic cell. In the case of simple cells, as is the case with microbes, entry occurs through the exposed cell surface; in complex organisms, by contrast, as in animals and humans, they enter the biological system via respiratory or gastrointestinal routes or through the skin. The nanoparticles are then taken up by cells and internal­ized by the processes of endocytosis or phagocytosis (Martinez etal., 2021).
The specic and non- specic biophysical interaction of nanomaterials with cellular organelles and subcellular components, serum proteins, blood cells, and intracellular compartments may alter their biological performance and functions and induce damage in DNA, leading to molecular initiat­ing events (MIE), adverse outcomes (AO) via adverse outcome pathways (AOP), culminating in nanotoxicity. These interactions may be initiated by physical, chemical, and mechanical forces in vivo or may be mediated by receptors (Liu etal., 2022; Catalano, 2021; Tirumala etal., 2021). Adverse events normally observed with NP are loss in integrity of cell membrane and nuclear mem­brane (in extreme cases); the dysregulation of mitochondrial function; the permeabilization of the lysosomal membrane; the elevation of ROS/RNS- induced oxidative stress; interference with signal transduction; and the over- production of pro- inammatory cytokines. These events are manifested as brosis, granuloma, organ damage, cardiac disturbances, genotoxicity, disruption in cell prolif­eration, apoptosis, necrosis, and other modes of cell death (Martinez etal., 2021; Korth, 2014). Among the various vital organs under potential risk from nanomedicines, liver, and kidneys arise rst due to nanopores present in sinusoidal blood vessels and the basement membrane of liver and the glomerular membrane of kidneys. NP greater than 5 nm cannot be cleared from the body by kidneys. The presence of a primary tumor in an adjacent organ may restrict the advance of NP to the desired target organ and, if entry is facilitated, must be able to ward off endosome- mediated degra­dation (Mengying etal., 2015 , Lokugamage etal., 2018 , Koklesova etal., 2023).
One issue that has been frequently overlooked by nanomaterial manufacturers and regulatory bodies associated with the production of engineered NPs for pharmaceutical applications is the issue of contamination of raw materials, intermediates, or nished products by microbes and endotoxins (Siegrist etal., 2019).
20.3 APPROACHES TOWARDS SAFETY AND TOXICOLOGICAL ASSESSMENT:
NANOTOXICOLOGY
In 2005 the International Life Sciences Institute Research Foundation/Risk Science Institute consti­tuted a working group with experts in the domain of nanomaterials with the aim of evaluating the state- of- the- art concerning toxicological aspects and framing guidelines. They realized the need for the screening of nanomaterials based on their hazard levels with standardized protocols (Hussain et al., 2015). Nanotoxicology deals with the identication, determination, and establishment of unintentional adverse effects, interactions, and toxicokinetics of engineered or manufactured nano­materials on target organisms(users), producers, and biotic and abiotic components of the environ­ment at cellular and molecular levels throughout their lifecycle (Liu etal., 2022; Tirumala etal., 2021; Akcan etal., 2020).
420 Herbal Pharmacopeia
Nanotoxicological studies become challenging as the same NPs can respond and behave differ­ently and may exhibit different effects on different types of cells, as is reported in studies on the effect of silver NPs on stem, nervous, epithelial, phagocytic, endothelial cells, and alveolar macro­phages. Moreover, site- specic nano- formulations and smart or intelligent nanoparticles are being envisaged to achieve targeted, controlled drug delivery at the site of action and release the cargo in response to various internal biological stimuli. The fabrication of such delivery platforms adds to the challenge in the assessment of toxicity and hazards (Abdelkader etal., 2023).
Development of ROS- induced oxidative stress has been elucidated as the primary toxic effect elicited by NPs in the biological environment and ecosystem, or as MIE, as dened previously by AOP. The excess of ROS alters protein conformation and alters the chemistry of lipids and nucleic acids, leading to apoptosis and necrosis (Martinez etal., 2021). Figure 20.1 summarizes the poten­tial impact of physicochemical attributes, in vivo attributes, and other factors associated with nanoparticles on their safety and toxicity.
Prime factors that are considered in nanotoxicological assessment involve the physicochemical characterization of nanomedicines/nanomaterials, followed by in vitro and in vivo investigations (Kad etal., 2022).
Safety and toxicity evaluation of NP should include both in vitro and in vivo methods preferably at an estimated human dose to have a clear idea about the effect of NP concentration on target and non- target tissues and organs (AzoNano). Nanotoxicological assessment can be carried out by adopting empirical approaches involving experimental data and computational techniques, and in silico approaches (Forest, 2022).
In empirical methods, humans, animals, and excised tissues or cells or cell lines are exposed to nanomaterials under investigation and the effects produced are recorded and compared to control data. The responses that are observed include the extent of cellular uptake, biodistribution, cell
FIGURE 20.1 Potential impact of herbal nanomedicines on safety and toxicity to man and his environment.
Safety Proles and Potential Toxicological Concerns of Herbal Nanomedicine 421
viability, proliferation, effects on biochemical pathways, signs of cytotoxicity such as elevated ROS levels, the development of oxidative stress, the overproduction of pro- inammatory cytokines, the induction of inammatory responses, and the integrity of the genome (Abdelkader etal., 2023).
However, before subjecting NP to a battery of in vitro and in vivo tests, it is essential to ensure the chemical composition of NP and to characterize their size and size distribution as these proper­ties affect their biological and toxic responses signicantly. For example, the purity of NP polymeric components, and the presence of surface coating can be analyzed through thermogravimetric analy­sis (TGA), mass spectrometry, or inductively coupled plasma mass spectrometry (ICP- MS). Particle size and size distribution can be effectively monitored by transmission electron microscopy (TEM), dynamic light scattering, Brunauer–Emmett–Teller (BET) adsorption isotherm, and electrospray differential mobility analysis (ES- DMA) techniques (Halamoda- Kenzaoui etal., 2019b). In the later methods, however, processing is required before actual characterization and that may induce arti­cial changes in surface properties which will not occur in vivo (Foulkes etal., 2020).

20.3.1 In VItro Methods

In vitro models are regarded as direct, convenient, reliable, accessible, and inexpensive surrogates of animal models, involving minimal ethical issues. During nano- formulation development, these should be carried out before animal studies. In in vitro studies, primary cell cultures (derived from cancer cells), cell lines articially immobilized in monoculture systems, multicellular 3D models or organoids, spheroids, and co- cultures are all widely employed. Among the examples are cells obtained from lungs, gastrointestinal tract, neurons, blood, liver, stem cell- derived hepatocytes, pluripotent stem cells (iPSCs), human fetal hepatic progenitor cells (hFHPCs), and human skin­derived precursors (hSKPs), and those of co- cultures are alveolar epithelial type II cells, two types of immune cells (human monocyte- derived macrophages and dendritic cells), three- dimensional lung co- culture comprising of alveolar epithelial cells- broblasts- macrophages, Caco- 2-HT29 co­culture, triple culture of Caco- 2, HT29-MTX- E12, and THP- 1 cells. Of these different systems, primary cell cultures and cell lines are useful in the preliminary stages of nanotoxicity assessment and produce reliable data. However, they fail to represent the heterogeneity and complexity of pharmacokinetics and toxicokinetics in the actual biological system resulting from crosstalk and interaction at multiple cellular levels and prolonged use may produce erroneous responses due to de- differentiation and phenotypic change. In such circumstances, co- cultures and 3D models have proven to be valuable and, in particular, the latter model can serve as a bridge between the 2D cell cultures and animal models (Forest, 2022; Tirumala etal., 2021).
During in vitro studies in different types of cell models, the endpoints are alterations in mem­brane integrity, cell viability, cytotoxicity, the estimation of oxidative stress, the lowering of anti­oxidant activities, nucleic acid, and chromosomal damage, alteration in genetic prole and expression, and apoptosis. The techniques widely employed are 3-(4,5-dimethylthiazol- 2-yl)-2,5­diphenyltetrazolium bromide (MTT) assay, Trypan blue assay, and 2’,7’-dichlorouorescein diace­tate assay (DCFDA). Instrumental methods of analyses adopted for detecting the endpoints are based on colorimetry, UV- Vis spectrophotometry, uorescence spectroscopy, luminescence, scan­ning electron microscopy (SEM), transmission electron microscopy (TEM), scanning electron microscopy/energy dispersive X- ray spectroscopy (SEM- EDX), atomic force microscopy (AFM), video- enhanced differential interference contrast (VEDIC) microscopy, and so on (Tirumala etal., 2021; Akcan etal., 2020). An interesting in vitro study has been conducted with a modied lipopoly­saccharide (LPS) membrane of Gram- negative bacteria to determine the effect of modication on binding of gold NP and subsequent penetration inside bacterial cells. Observations with modied bacteria and solid- supported LPS- containing lipid bilayers revealed LPS to be the essential compo­nent for NP- microbial cell surface interaction. To increase the sensitivity of toxicity screening assays, E. coli knockout mutants were employed which provided desirable information on the cel­lular response to NPs, in comparison to wild varieties (Qiu etal., 2018). Latest developments in in
422 Herbal Pharmacopeia
vitro methods for nanotoxicological studies involve the inclusion of cells, tissues or organs- on- a­chip producing cell- on- a- chip or organ- on- a- chip on a microuidic platform. This system facilitates dynamic characterization. The toxicity of titanium dioxide or zinc oxide nanoparticles in lungs has been evaluated by lung- on- a- chip model (Forest, 2022; Akcan etal., 2020). 3D epidermal models, such as the EpiKutis model and the Ediderm skin model, have demonstrated a more accurate predic­tion of NP- induced skin toxicity. A 3D hepatocyte chip is yet to be developed for the accurate assess­ment of NP- induced liver injury and hepatotoxicity (Tirumala etal., 2021).
Genotoxicity assessment is a crucial part of in vitro assay portfolio in nanotoxicological studies, for which the tests commonly employed are Salmonella typhimurium reverse mutation assay (AMES), COMET, chromosomal aberration, micronucleus, and hypoxanthine phosphorybosyl transferase (HPRT) mutation assays (Verma, 2018). However, none of them is capable of providing a complete picture of genotoxic potential; there may even be false positive or negative results due to the interfer­ence and interaction of NPs with assay reagents such as that between cytochalasin B and nanomateri­als in micronucleus assay, inability, or incomplete penetration of NP into bacterial cells in AMES test, risk of interaction with naked DNA in COMET assay (Tirumala etal., 2021). Interactions occur due to the unique characteristics of NPs such as adsorption efciency, chemical reactivity, optical and magnetic properties, and other physicochemical characteristics (Soares etal., 2018).
Despite several merits of in vitro tools, they fail to mimic the effects in the case of repeated use in the management of chronic conditions. It is challenging to carry out such simulations for a pro­longed duration. Growth promoters, nutrients, and proteins present in articial culture media used for the growth and maintenance of cell lines and cell cultures may be absorbed by NPs. NPs may interact with dyes used in various colorimetric, spectrometric, and uorescent methods. Assays involving estimation of optical parameters or measuring products of redox reactions may fail to give accurate results. In vitro test conditions do not emulate the tissue/tumor microenvironment and may be compromised leading to loss in reproducibility and precision of experimental data (Kad etal., 2022, Foulkes etal., 2020; Mengying etal., 2015). Neither of the in vitro cell- based models can mimic the actual pathophysiological response to potentially toxic NP, nor can they reproduce the compensation mechanism exhibited by humans or animals in response to challenge with NP in clini­cal settings (Soares etal., 2018).

20.3.2 In VIVo AssAys

In vivo assays are performed in animal models such as drosophila, zebrash, rats, mice, and other non- human primates, and attempts are usually made to use relevant doses at which they will be used for therapeutic effects. The objective of in vivo studies is to characterize biodistribution and uptake by organs such as the brain, with the help of microdialysis, sampling of cerebrospinal uid, quantication of brain uptake index, quantitative radiography, and various imaging methods (Kad etal., 2022). A plethora of imaging techniques are available at hand such as laser confocal microscopy (LCM), laser ablation inductively coupled plasma mass spectrometry (LA- ICP- MS), transmission electron microscopy electron energy loss spectroscopy (TEM- EELS), transmission electron microscopy energy dispersive X- ray analysis (TEM- EDX), synchrotron radiation micro­beam techniques like synchrotron radiation X- ray uorescence (SRXRF), and synchrotron- based X- ray absorption spectroscopy (SRXAS), dark eld microscopy. Techniques such as solution NMR, surface- enhanced Raman spectroscopy (SERS), attenuated total reectance- Fourier transform infrared (ATR- FTIR) spectroscopy , synchrotron radiation- based circular dichroism (SR- CD) with high light ux in ultraviolet regions, surface plasmon resonance SPR, quartz crystal microbalance (QCM), and hyper- spectral imaging help in studying absorption and penetration kinetics, composi­tion and conformational changes of adsorbed proteins, the identication of chemical composition of protein corona, intracellular agglomeration, and spatial and temporal biodistribution (Liu etal., 2022; Tirumala etal., 2021; Ramanathan, 2019; Hussain etal., 2015). In addition to these imag­ing techniques and instrumental methods of analysis, biochemical tests, hematological tests, and
Safety Proles and Potential Toxicological Concerns of Herbal Nanomedicine 423
histopathological studies are performed. In vivo assays in whole organisms can simulate pathophys­iological responses, and cellular and subcellular interactions at multiple levels, provide an idea of the various defense mechanisms, tissue- repairing phenomena, biopersistence, and the accumulation of nano- formulations. They can predict the pharmacokinetics and toxicokinetics of nanomaterials. Long- term efcacy and chronic toxicity studies can be done easily in animals. Although in the pre­ceding discussion, it has been mentioned that genotoxicity can be predicted by in vitro techniques, advancements have been made in the development of genotoxicity assays in a single animal spe­cies, most similar to humans. The genotoxicity of titanium dioxide and silica nanoparticles has been investigated in rodents (Forest, 2022). Although different animal species have been tried for in vivo testing of NP for safety and toxicity, the accuracy of results may be compromised owing to inter- species biochemical and genetic differences. The same limitation is applicable in immunotox­icity assessment for anti- cancer nanomedicines in rodent models. The biodistribution of NPs can be studied in humanized mouse models to overcome the limitation of rodent model. Animal models are likely to help investigate T- cell- Dependent Antibody Response (TDAR) (Ray etal., 2021).
However, experimental nanotoxicological methods are not based on standardized protocols and the outcomes of the experiments may vary with the selection of specic cell lines, cell culture medium composition, and the dispersion technique of nano- formulations. Moreover, dose calcula­tion, its basis, and allometric scaling of dose may be inappropriate in several circumstances. The availability of positive control is scarce (Forest, 2022).
One common problem associated with in vitro and in vivo techniques in experimental toxicologi­cal studies is the lack of certied reference materials for most nano- formulations and nanomedi­cines. Certain reference criteria are available in ofcially recommended guidelines for the size and surface area of titanium dioxide, cellulose nanocrystals, gold, silica, and silver NPs. In the case of commonly used liposomal preparations and NPs fabricated with biodegradable polymers, no such reference material is yet available (Halamoda- Kenzaoui etal., 2019b). Regarding dose administra­tion in animals, it has been frequently observed that doses for in vitro and in vivo data acquisition are different, leading to complications in the interpretation of pharmacokinetics and toxicokinetics. Usually, acute high dose or concentration is used to elucidate mechanisms for inducing toxicity and predict dose- dependent effects during in vitro studies, which is irrelevant for in vivo studies. Moreover, effects and responses attributed to a single high dose will be entirely different from those with chronic multiple or repeated administration of low doses due to accumulation effect and reten­tion in the systemic circulation. Although repeated dose administration can be adopted during in vivo tests, such a strategy escalates the cost of experimentation, and is also time- consuming (Forest, 2022; Mengying etal., 2015).
However, available techniques fail to detect the effects and endpoints of exposing in vitro cell­based models or in vivo animal models to chronic low doses, for which more sensitive, precise, reliable, and innovative methods need to be developed and an in- depth understanding of molecular biology is also essential (Tirumala etal., 2021; Mengying etal., 2015). Despite progress in in vitro and in vivo techniques for nanotoxicity assessment, it has been difcult to establish a denite cause­and- effect relationship due to the above- mentioned factors and lacunae associated with the tech­niques being currently practiced. The relationship may be established successfully if the problem of interference of NPs with assay reagents can be overcome and appropriate techniques can be devel­oped for real- time in situ monitoring of NP- cell membrane interface interaction and changes in chemical composition and conformation of the adsorbed proteins in the corona (Qiu etal., 2018).
Developments in the design of engineered nanomedicines and nano- formulations with custom­ized properties and multiple functions are increasing the complexities in assessing their toxicity and hazard potential. The preceding discussion reveals the lack of human relevance of in vitro and in vivo data obtained by conventional methods. Little correlation is observed between in vitro and in vivo data. These techniques are not able to give a clear picture of the in vivo fate of NPs. To address these problems, the European Union Reference Laboratory for Alternatives to Animal Testing rec­ommended the use of donor- derived human cell lines, during in vitro tests , instead of articial